Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # FDA Approval
  • # Hoffmann-La Roche
  • # Johnson&Johnson
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Researchers discovered that male and female microglia function differently

22 January 2025

Blood test for Tuberculosis; researchers at the final phase of development

23 March 2024

AstraZeneca Released Satisfactory Results of 24 Weeks CALYPSO Phase III Trial for Eneboparatide

17 March 2025

Moderna Reports Q1 2025 Results: Revenue Dips, Focus Shifts to Oncology Amid Expense Cuts

4 May 2025

Bone regeneration treatments could be improved by new Bioengineering research

11 June 2024

Aldeyra Therapeutics Responds to the U.S. FDA’s Denial of Reproxalap’s NDA Application for Treating Signs and Symptoms of Dry Eye Disease

3 April 2025

Pfizer’s HYMPAVZI™ Shows Strong Efficacy in Late-Stage Hemophilia Trial

27 June 2025

Mitosis: Definition, Stages, Mechanism of Cell Division, and Diagrams

1 December 2023

Eyestem Announces Positive Safety Results in Phase 1 Trial of RPE Cell Therapy

18 June 2025

UK approves first in the world CRISPR treatment for diseases – Casgevy

17 November 2023

One letter difference in the DNA can generate an immune response

16 December 2023

WHO declares conclusion to COVID-19’s emergency phase

10 May 2023

HIV

Gilead Provides Clinical Update on Investigational HIV-1 Treatments GS-1720 and GS-4182
Clinical Trials Healthcare & Pharmaceuticals News

Gilead Provides Clinical Update on Investigational HIV-1 Treatments GS-1720 and GS-4182

Ajmal Aseem 10 June 2025

Gilead has paused dosing in its Phase 1b studies of GS-1720 and GS-4182—two promising long-acting HIV-1 therapies after identifying tolerability issues. No serious adverse events were reported, and the company is evaluating future development pathways.

HIV Vaccine Trial Success: Scripps and IAVI Use mRNA to Target bnAbs
Clinical Trials Healthcare & Pharmaceuticals News Vaccines

HIV Vaccine Trial Success: Scripps and IAVI Use mRNA to Target bnAbs

Ajmal Aseem 17 May 2025

The stepwise vaccination approach successfully activated and matured B cells toward producing broadly neutralizing antibodies, marking a major milestone in the pursuit of an effective HIV vaccine.

GSK Released EMBRACE a Phase 2b Clinical Trial Data of an Investigational Broadly Neutralising Antibody for HIV
Business Clinical Trials Healthcare & Pharmaceuticals News

GSK Released EMBRACE a Phase 2b Clinical Trial Data of an Investigational Broadly Neutralising Antibody for HIV

Editor's Desk 18 March 2025

The findings support the increasing amount of data showing that N6LS is a strong antiviral that may be used as part of an all-encompassing antiretroviral treatment plan.

Merck Announces Positive Results of Phase 3 Trials for Their HIV-1 Investigational Two-Drug Regimen Doravirine/Islatravir
Clinical Trials Healthcare & Pharmaceuticals News

Merck Announces Positive Results of Phase 3 Trials for Their HIV-1 Investigational Two-Drug Regimen Doravirine/Islatravir

Editor's Desk 13 March 2025

Islatravir, Merck’s investigational nucleoside reverse transcriptase translocation inhibitor (NRTTI), inhibits HIV-1 replication through a variety of mechanisms

Research Identifies Gene Regulation of AIDS Causing HIV Virus
News Research Virology

Research Identifies Gene Regulation of AIDS Causing HIV Virus

Ajmal Aseem 18 January 2025

HIV-1, like other viruses, lacks the equipment to generate its own proteins and must rely on the host cell to translate its genetic instructions.

Twice-yearly injections are 99% efficient at preventing HIV, according to a clinical study
Clinical Trials News

Twice-yearly injections are 99% efficient at preventing HIV, according to a clinical study

Editor's Desk 30 November 2024

A twice-yearly injection of Lenacapavir, however, offers a 96% lower risk of infection overall.

New antibody therapy to neutralize a wide variety of HIV-1 strains
Healthcare & Pharmaceuticals News Research

New antibody therapy to neutralize a wide variety of HIV-1 strains

Editor's Desk 19 July 2024

This new study offers a broadly useful technique to improve nanobodies’ performance. Artificially created antibody fragments, known as nanobodies, are around 10 times smaller than regular antibodies.

HIV – Human Immunodeficiency Virus | Details
Disease Biology Diseases

HIV – Human Immunodeficiency Virus | Details

Athulya B S 18 August 2023

HIV (human immunodeficiency virus) is a virus that attacks the human immune system, grouped under the genus Lentivirus and family retroviridae. Studies say that HIV infection in humans originated from a chimpanzee in Central Africa and the virus that affects chimpanzees is called as Simian immunodeficiency virus (SIV).

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Cytiva Hiring a Quality Control Technician in Cardiff, United Kingdom
  • PhD Position in Dialysis Therapy – University of Twente, Netherlands
  • Eli Lilly and Company Hiring a Analytical Technical Steward-Peptides in Hyderabad, India – June, 2025
  • ICON Hiring a Clinical Data Programming Lead in Chennai, India
  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
SciRealityPress BiotechReality

A SciRealityPress Associate

DMCA.com Protection Status

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy